Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Smead Value C (SVFCX) Financials

Smead Value C logo
$77.22 -0.26 (-0.34%)
As of 08/14/2025
Compare
Annual Income Statements for Smead Value C

Annual Income Statements for Smead Value C

This table shows Smead Value C's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Net Income / (Loss) Attributable to Common Shareholders		 -110 0.00 -6.86 -24 -13
Consolidated Net Income / (Loss)		 -110 -122 -139 -208 -85
Net Income / (Loss) Continuing Operations		 -110 -122 -139 -208 -85
Total Pre-Tax Income 		-110 -122 -139 -213 -80
Total Operating Income		 -110 -122 -140 -223 -117
Total Gross Profit		 -19 10 100 190 246
Total Revenue		 92 252 593 1,177 1,788
Operating Revenue		 92 252 593 1,177 1,788
Total Cost of Revenue		 111 241 494 987 1,543
Operating Cost of Revenue		 111 241 494 987 1,543
Total Operating Expenses		 91 133 240 413 362
Selling, General & Admin Expense		 36 59 116 218 189
Research & Development Expense		 56 73 124 195 173
Total Other Income / (Expense), net		 0.81 0.07 1.29 11 37
Other Income / (Expense), net		 0.81 0.07 1.29 11 37
Income Tax Expense		 -0.05 0.00 0.00 -4.62 4.21
Other Gains / (Losses), net		 - - 0.00 0.00 -0.78
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 -60 -184 -71
Basic Earnings per Share		 $0.00 $0.00 ($0.13) ($0.37) ($0.14)
Weighted Average Basic Shares Outstanding		 0.00 0.00 54.09M 64.34M 95.70M
Diluted Earnings per Share		 $0.00 $0.00 ($0.13) ($0.37) ($0.14)
Weighted Average Diluted Shares Outstanding		 0.00 0.00 54.09M 64.34M 95.70M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 553.91M 557.24M 587.42M

Quarterly Income Statements for Smead Value C

This table shows Smead Value C's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Net Income / (Loss) Attributable to Common Shareholders		 -7.19 -6.12 -4.35 -6.21 -2.84 -8.81 -4.68 2.84 -3.48 -3.93 -5.91
Consolidated Net Income / (Loss)		 -68 -55 -39 -45 -19 -55 -27 16 -19 -21 -32
Net Income / (Loss) Continuing Operations		 -68 -55 -39 -45 -19 -55 -27 16 -19 -21 -32
Total Pre-Tax Income 		-68 -55 -39 -50 -19 -55 -26 20 -17 -20 -28
Total Operating Income		 -70 -58 -42 -54 -25 -65 -38 11 -25 -32 -37
Total Gross Profit		 35 43 53 59 64 30 55 96 80 108 108
Total Revenue		 206 267 312 392 360 393 470 565 487 550 592
Operating Revenue		 206 267 312 392 360 393 470 565 487 550 592
Total Cost of Revenue		 171 224 259 333 296 363 415 468 407 442 484
Operating Cost of Revenue		 171 224 259 333 296 363 415 468 407 442 484
Total Operating Expenses		 105 101 95 113 89 95 93 86 105 140 144
Selling, General & Admin Expense		 54 51 46 67 47 49 48 45 61 78 76
Research & Development Expense		 51 50 49 46 42 46 45 40 44 62 52
Restructuring Charge		 - - - - - - 0.00 - - - 16
Total Other Income / (Expense), net		 1.83 2.28 2.94 3.66 6.20 9.81 12 9.42 7.82 12 8.45
Other Income / (Expense), net		 1.83 2.28 2.94 3.66 6.20 9.81 12 9.42 7.82 12 8.45
Income Tax Expense		 0.25 -0.02 0.01 -4.86 0.17 -0.25 0.18 4.11 0.15 -1.40 0.04
Other Gains / (Losses), net		 - - 0.00 - 0.00 0.00 -0.54 - -1.56 -2.49 -3.78
Net Income / (Loss) Attributable to Noncontrolling Interest		 -61 -49 -35 -39 -16 -46 -22 13 -15 -18 -26
Basic Earnings per Share		 ($0.12) ($0.10) ($0.07) ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05)
Weighted Average Basic Shares Outstanding		 58.24M 60.50M 61.78M 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M
Diluted Earnings per Share		 ($0.12) ($0.10) ($0.07) ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05)
Weighted Average Diluted Shares Outstanding		 58.24M 60.50M 61.78M 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M
Weighted Average Basic & Diluted Shares Outstanding		 555.52M 555.46M 555.85M 557.24M 577.06M 584.63M 585.58M 587.42M 588.39M 589.61M 590.49M

Annual Cash Flow Statements for Smead Value C

This table details how cash moves in and out of Smead Value C's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Net Change in Cash & Equivalents		 -30 98 197 -93 469
Net Cash From Operating Activities		 -124 110 -148 231 -58
Net Cash From Continuing Operating Activities		 -124 110 -148 231 -58
Net Income / (Loss) Continuing Operations		 -110 -122 -139 -208 -85
Consolidated Net Income / (Loss)		 -110 -122 -139 -208 -85
Depreciation Expense		 5.73 4.49 5.99 11 23
Non-Cash Adjustments To Reconcile Net Income		 0.11 0.15 32 179 136
Changes in Operating Assets and Liabilities, net		 -21 227 -47 248 -133
Net Cash From Investing Activities		 -5.06 -12 -18 -299 156
Net Cash From Continuing Investing Activities		 -5.07 -12 -18 -299 156
Purchase of Property, Plant & Equipment		 -5.07 -12 -18 -21 -44
Acquisitions		 - - 0.00 0.00 -90
Purchase of Investments		 - 0.00 0.00 -408 -49
Sale of Property, Plant & Equipment		 - 0.00 0.00 0.07 0.00
Sale and/or Maturity of Investments		 - 0.00 0.00 130 340
Net Cash From Financing Activities		 100 0.00 362 -24 371
Net Cash From Continuing Financing Activities		 100 0.00 362 -24 371
Payment of Dividends		 0.00 0.00 -300 0.00 -48
Issuance of Common Equity		 0.00 0.00 0.00 2.57 264
Other Financing Activities, net		 0.00 0.00 662 -27 156
Effect of Exchange Rate Changes		 -0.68 0.97 0.57 0.23 -0.00

Quarterly Cash Flow Statements for Smead Value C

This table details how cash moves in and out of Smead Value C's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Net Change in Cash & Equivalents		 -2.73 -92 -1.46 3.29 227 416 -31 -143 176 52 -177
Net Cash From Operating Activities		 101 31 54 45 -30 21 50 -99 205 270 -138
Net Cash From Continuing Operating Activities		 101 31 54 45 -30 21 50 -99 205 270 -138
Net Income / (Loss) Continuing Operations		 -68 -55 -39 -45 -19 -55 -47 16 -19 -21 -32
Consolidated Net Income / (Loss)		 -68 -55 -39 -45 -19 -55 -47 16 -19 -21 -32
Depreciation Expense		 2.08 2.07 2.46 4.71 3.20 3.16 11 6.43 7.65 12 14
Non-Cash Adjustments To Reconcile Net Income		 50 41 37 51 30 53 28 25 28 43 57
Changes in Operating Assets and Liabilities, net		 117 43 53 34 -44 19 59 -147 188 235 -178
Net Cash From Investing Activities		 -104 -112 -55 -28 99 137 -34 -45 -25 -221 -39
Net Cash From Continuing Investing Activities		 -104 -112 -55 -28 99 137 -34 -45 -25 -221 -39
Purchase of Property, Plant & Equipment		 -6.99 -6.02 -7.36 -0.96 -2.99 -2.87 -17 -21 -7.36 -21 -15
Acquisitions		 - - - - 0.00 - - -24 -18 -200 -24
Net Cash From Financing Activities		 0.00 -11 - -13 159 258 -48 1.75 -3.86 2.85 0.06
Net Cash From Continuing Financing Activities		 0.00 -11 - -13 159 258 -48 1.75 -3.86 2.85 0.06
Payment of Dividends		 - - - - 0.00 - - -0.56 -0.85 -0.38 0.06
Effect of Exchange Rate Changes		 0.02 - -0.05 0.14 -0.00 -0.01 -0.01 0.02 -0.08 0.05 0.02

Annual Balance Sheets for Smead Value C

This table presents Smead Value C's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Total Assets		 0.13 281 631 1,051 1,579
Total Current Assets		 0.01 260 605 992 1,356
Cash & Equivalents		 0.00 157 353 259 727
Accounts Receivable		 - 63 105 190 420
Inventories, net		 - 34 92 136 106
Prepaid Expenses		 0.01 6.37 26 85 101
Other Current Assets		 - 0.49 29 35 1.06
Plant, Property, & Equipment, net		 0.00 19 25 35 97
Total Noncurrent Assets		 0.13 1.50 0.99 24 126
Long-Term Investments		 - - - 0.00 81
Goodwill		 - - - - 0.00
Intangible Assets		 - 1.16 0.65 0.22 3.66
Other Noncurrent Operating Assets		 0.13 0.33 0.34 24 41
Total Liabilities & Shareholders' Equity		 0.13 281 631 1,051 1,579
Total Liabilities		 0.13 558 562 1,053 1,188
Total Current Liabilities		 0.13 337 523 1,025 1,017
Accounts Payable		 0.01 28 68 110 175
Accrued Expenses		 0.10 31 47 128 166
Current Deferred Revenue		 - 259 394 787 676
Total Noncurrent Liabilities		 0.00 221 39 28 171
Noncurrent Deferred Revenue		 - 217 31 0.00 129
Other Noncurrent Operating Liabilities		 0.00 3.99 7.90 28 42
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.01 -1,113 69 -2.72 390
Total Preferred & Common Equity		 0.01 0.00 7.18 0.08 197
Total Common Equity		 0.01 -1,113 7.18 0.08 197
Common Stock		 0.03 17 1,238 1,254 1,524
Retained Earnings		 -0.02 -1,155 -1,287 -1,310 -1,324
Accumulated Other Comprehensive Income / (Loss)		 - -2.09 -2.29 -1.69 -2.59
Noncontrolling Interest		 - 0.00 62 -2.80 193

Quarterly Balance Sheets for Smead Value C

This table presents Smead Value C's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/25/2022 12/24/2022 3/25/2023 6/24/2023 12/30/2023 3/30/2024 6/29/2024 12/28/2024 3/29/2025 6/28/2025
Total Assets		 613 809 910 970 1,316 1,553 1,500 1,716 1,964 1,827
Total Current Assets		 591 772 866 922 1,251 1,449 1,313 1,458 1,498 1,426
Cash & Equivalents		 412 351 257 255 486 901 870 903 955 778
Accounts Receivable		 2.55 146 188 165 293 267 203 358 298 373
Inventories, net		 127 111 140 167 138 120 132 109 146 139
Prepaid Expenses		 49 32 39 36 104 110 101 86 94 102
Other Current Assets		 0.55 35 37 42 42 1.17 6.75 3.22 4.98 36
Plant, Property, & Equipment, net		 21 30 36 41 35 75 81 105 124 73
Total Noncurrent Assets		 1.14 6.60 7.59 7.17 30 29 106 152 342 328
Long-Term Investments		 - - - - - - - 86 85 106
Goodwill		 - - - - - - - - 69 61
Intangible Assets		 0.80 0.54 0.43 0.34 0.00 0.00 0.00 15 126 83
Other Noncurrent Operating Assets		 0.34 6.06 7.16 6.83 30 29 106 51 63 79
Total Liabilities & Shareholders' Equity		 613 809 910 970 1,316 1,553 1,500 1,716 1,964 1,827
Total Liabilities		 540 759 888 948 1,150 1,159 1,154 1,322 1,543 1,384
Total Current Liabilities		 445 736 850 898 1,096 1,076 1,023 1,197 1,473 1,317
Accounts Payable		 97 61 88 74 103 133 128 206 220 216
Accrued Expenses		 51 73 71 61 116 119 177 203 166 184
Current Deferred Revenue		 290 580 665 742 840 815 718 787 1,086 918
Total Noncurrent Liabilities		 95 23 38 50 54 83 131 125 70 67
Noncurrent Deferred Revenue		 89 9.34 24 33 17 45 82 77 8.15 5.04
Other Noncurrent Operating Liabilities		 5.98 13 15 17 37 39 49 48 62 62
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 73 50 21 22 166 394 347 394 422 443
Total Preferred & Common Equity		 7.01 5.32 2.37 2.48 -57 197 197 197 205 211
Total Common Equity		 0.00 5.32 2.37 2.48 -57 197 197 197 205 211
Common Stock		 1,232 1,243 1,246 1,250 1,258 1,522 1,526 1,527 1,539 1,551
Retained Earnings		 -1,281 -1,294 -1,300 -1,304 -1,313 -1,322 -1,327 -1,327 -1,331 -1,337
Accumulated Other Comprehensive Income / (Loss)		 -2.14 -2.31 -2.09 -1.83 -1.77 -2.37 -2.63 -2.70 -2.70 -2.68
Noncontrolling Interest		 66 45 19 19 223 197 150 197 216 233

Annual Metrics And Ratios for Smead Value C

This table displays calculated financial ratios and metrics derived from Smead Value C's official financial filings.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 173.56% 135.52% 98.36% 51.94%
EBITDA Growth		 0.00% -13.47% -12.97% -51.17% 72.07%
EBIT Growth		 0.00% -11.63% -13.71% -52.79% 62.50%
NOPAT Growth		 0.00% -10.88% -14.70% -59.02% 47.71%
Net Income Growth		 0.00% -11.68% -13.71% -49.47% 59.27%
EPS Growth		 0.00% 0.00% 0.00% -184.62% 62.16%
Operating Cash Flow Growth		 0.00% 188.14% -235.30% 255.68% -125.16%
Free Cash Flow Firm Growth		 0.00% 0.00% -171.09% 143.44% -296.81%
Invested Capital Growth		 0.00% -1,814,030.72% 34.38% -92.69% 23.67%
Revenue Q/Q Growth		 0.00% 0.00% 26.42% 14.33% 8.05%
EBITDA Q/Q Growth		 0.00% 0.00% 17.77% 2.85% 48.21%
EBIT Q/Q Growth		 0.00% 0.00% 16.88% 1.38% 38.83%
NOPAT Q/Q Growth		 0.00% 0.00% 16.26% 0.17% 27.75%
Net Income Q/Q Growth		 0.00% 0.00% 17.53% 3.04% 32.83%
EPS Q/Q Growth		 0.00% 0.00% -218.18% 5.13% 36.36%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -78.21% 71.28% -167.66%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 1,957.58% -168.75%
Invested Capital Q/Q Growth		 0.00% 0.00% 15.96% -12.05% 20.09%
Profitability Metrics		 - - - - -
Gross Margin		 -20.56% 4.15% 16.80% 16.12% 13.74%
EBITDA Margin		 -112.76% -46.77% -22.43% -17.10% -3.14%
Operating Margin		 -119.86% -48.58% -23.66% -18.97% -6.53%
EBIT Margin		 -118.98% -48.55% -23.44% -18.06% -4.46%
Profit (Net Income) Margin		 -118.93% -48.55% -23.44% -17.66% -4.74%
Tax Burden Percent		 99.96% 100.00% 100.00% 97.83% 106.26%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -323,225.82% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -504,955.96% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -1,456,445.94% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -1,779,671.76% 88.33% 133.72% -627.85% -43.71%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -82,441.46% -87.16% -30.51% -25.27% -6.06%
Return on Assets (ROA)		 -82,406.10% -87.16% -30.51% -24.72% -6.44%
Return on Common Equity (ROCE)		 -1,779,671.76% 355.02% 710.97% -68.89% -22.26%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -1,936.09% 0.00% -42.93%
Net Operating Profit after Tax (NOPAT)		 -77 -86 -98 -156 -82
NOPAT Margin		 -83.90% -34.01% -16.56% -13.28% -4.57%
Net Nonoperating Expense Percent (NNEP)		 181,730.14% -46.80% -16.01% -11.49% -0.44%
Cost of Revenue to Revenue		 120.56% 95.85% 83.21% 83.88% 86.26%
SG&A Expenses to Revenue		 38.64% 23.60% 19.53% 18.52% 10.57%
R&D to Revenue		 60.66% 29.13% 20.92% 16.57% 9.70%
Operating Expenses to Revenue		 99.31% 52.73% 40.45% 35.09% 20.27%
Earnings before Interest and Taxes (EBIT)		 -110 -122 -139 -213 -80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -104 -118 -133 -201 -56
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 45,498.86 0.00 809.95 226,609.56 75.77
Price to Tangible Book Value (P/TBV)		 45,498.86 0.00 890.52 0.00 77.20
Price to Revenue (P/Rev)		 3.04 1.60 9.81 15.79 8.36
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11,714.26 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 3.04 4.29 9.32 15.32 8.01
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 9.87 0.00 78.14 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 3.11 0.00 167.84 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 2.88 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 2.88 0.57 2.45 -13.57 -3.50
Leverage Ratio		 21.60 -1.01 -4.38 25.40 6.79
Compound Leverage Factor		 21.60 -1.01 -4.38 25.40 6.79
Debt to Total Capital		 74.26% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 74.26% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -301.93% 89.58% 103.02% 49.44%
Common Equity to Total Capital		 25.74% 401.93% 10.42% -3.02% 50.56%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -703.54 -6.20 3.72 9.25 7.59
Noncontrolling Interest Sharing Ratio		 0.00% -301.94% -431.68% 89.03% 49.07%
Liquidity Ratios		 - - - - -
Current Ratio		 0.05 0.77 1.16 0.97 1.33
Quick Ratio		 0.00 0.65 0.88 0.72 1.13
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 348 -247 107 -211
Operating Cash Flow to CapEx		 -2,451.33% 900.45% -825.89% 1,085.83% -130.88%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 692.88 1.80 1.30 1.40 1.36
Accounts Receivable Turnover		 0.00 0.00 7.04 7.96 5.86
Inventory Turnover		 0.00 0.00 7.87 8.66 12.73
Fixed Asset Turnover		 0.00 0.00 27.28 39.64 27.17
Accounts Payable Turnover		 12,335.11 17.23 10.24 11.07 10.82
Days Sales Outstanding (DSO)		 0.00 0.00 51.86 45.84 62.27
Days Inventory Outstanding (DIO)		 0.00 0.00 46.38 42.16 28.66
Days Payable Outstanding (DPO)		 0.03 21.18 35.66 32.98 33.73
Cash Conversion Cycle (CCC)		 -0.03 -21.18 62.58 55.02 57.20
Capital & Investment Metrics		 - - - - -
Invested Capital		 0.02 -434 -285 -548 -418
Invested Capital Turnover		 3,852.33 -1.16 -1.65 -2.83 -3.70
Increase / (Decrease) in Invested Capital		 0.00 -434 149 -264 130
Enterprise Value (EV)		 280 1,082 5,527 18,034 14,328
Market Capitalization		 280 402 5,819 18,582 14,944
Book Value per Share		 $0.00 ($27.13) $0.01 $0.00 $0.34
Tangible Book Value per Share		 $0.00 ($27.15) $0.01 $0.00 $0.33
Total Capital		 0.02 -277 69 -2.72 390
Total Debt		 0.02 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.02 -157 -353 -546 -809
Capital Expenditures (CapEx)		 5.07 12 18 21 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.10 -233 -271 -579 -389
Debt-free Net Working Capital (DFNWC)		 -0.10 -77 82 -34 338
Net Working Capital (NWC)		 -0.12 -77 82 -34 338
Net Nonoperating Expense (NNE)		 32 37 41 52 2.96
Net Nonoperating Obligations (NNO)		 0.02 -157 -353 -546 -809
Total Depreciation and Amortization (D&A)		 5.73 4.49 5.99 11 23
Debt-free, Cash-free Net Working Capital to Revenue		 -0.11% -92.57% -45.68% -49.21% -21.75%
Debt-free Net Working Capital to Revenue		 -0.11% -30.39% 13.90% -2.86% 18.92%
Net Working Capital to Revenue		 -0.13% -30.39% 13.90% -2.86% 18.92%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.38) ($0.13) ($0.37) ($0.14)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 41.40M 54.09M 64.34M 95.70M
Adjusted Diluted Earnings per Share		 $0.00 ($0.38) ($0.13) ($0.37) ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 41.40M 54.09M 64.34M 95.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($0.38) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 34.61M 553.91M 557.24M 587.42M
Normalized Net Operating Profit after Tax (NOPAT)		 -77 -86 -98 -156 -82
Normalized NOPAT Margin		 -83.90% -34.01% -16.56% -13.28% -4.57%
Pre Tax Income Margin		 -118.98% -48.55% -23.44% -18.06% -4.46%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% -215.69% 0.00% -56.94%
Augmented Payout Ratio		 0.00% 0.00% -215.69% 0.00% -56.94%

Quarterly Metrics And Ratios for Smead Value C

This table displays calculated financial ratios and metrics derived from Smead Value C's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 167.72% 177.15% 77.63% 60.34% 74.47% 47.40% 50.83% 44.06% 35.21% 39.74% 25.89%
EBITDA Growth		 -202.64% -87.33% -16.42% 11.46% 76.08% 2.69% 58.19% 158.67% 41.66% 84.47% 9.18%
EBIT Growth		 -193.82% -85.38% -18.85% 5.60% 72.10% 0.63% 33.44% 140.39% 11.08% 63.06% -8.08%
NOPAT Growth		 -201.49% -92.64% -27.18% 0.69% 63.92% -12.43% 10.45% 123.00% 1.87% 50.60% 2.83%
Net Income Growth		 -194.91% -85.32% -14.30% 12.57% 71.95% 1.06% 31.61% 135.13% 2.89% 60.90% -19.46%
EPS Growth		 0.00% 0.00% -133.33% 20.00% 75.00% 10.00% 28.57% 137.50% 0.00% 55.56% 0.00%
Operating Cash Flow Growth		 152.63% 130.43% 259.35% 186.43% -129.84% -32.70% -6.53% -323.19% 780.02% 1,179.30% -374.58%
Free Cash Flow Firm Growth		 9,936.94% 39.97% 202.66% 220.76% -85.46% -82.21% -93.35% -153.58% -27.31% -45.94% -1,457.34%
Invested Capital Growth		 -232.02% 0.00% -44.53% -92.69% -28.19% -26.46% -7.03% 23.67% -16.86% -10.93% 16.03%
Revenue Q/Q Growth		 -15.59% 29.34% 16.86% 25.67% -8.15% 9.28% 10.85% 20.03% -13.79% 12.94% 7.73%
EBITDA Q/Q Growth		 -27.57% 18.72% 31.39% -24.46% 65.54% -230.68% 59.70% 274.64% -134.26% 11.95% -72.37%
EBIT Q/Q Growth		 -27.18% 18.16% 29.51% -28.67% 62.41% -191.44% 36.79% 178.08% -182.77% -21.06% -38.14%
NOPAT Q/Q Growth		 -28.10% 17.04% 27.22% -28.39% 53.46% -158.55% 26.17% 132.98% -298.53% -30.17% -14.03%
Net Income Q/Q Growth		 -30.88% 18.49% 29.48% -16.22% 58.01% -187.49% 34.74% 159.70% -216.08% -15.76% -48.92%
EPS Q/Q Growth		 -20.00% 16.67% 30.00% -14.29% 62.50% -200.00% 28.57% 160.00% -200.00% -33.33% -25.00%
Operating Cash Flow Q/Q Growth		 296.15% -69.01% 72.14% -17.39% -167.71% 169.89% 139.10% -297.25% 306.30% 31.48% -151.32%
Free Cash Flow Firm Q/Q Growth		 447.08% -38.31% -69.71% 86.23% -58.22% -24.49% -86.78% -1,600.05% 156.68% -43.84% -384.29%
Invested Capital Q/Q Growth		 -39.61% -11.02% -10.94% -12.05% 7.12% -9.53% 2.61% 20.09% -42.20% -3.97% 28.93%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 17.06% 16.06% 16.97% 15.00% 17.80% 7.68% 11.69% 17.08% 16.45% 19.62% 18.18%
EBITDA Margin		 -31.82% -20.00% -11.74% -11.63% -4.36% -13.20% -3.25% 4.74% -1.88% -1.47% -2.35%
Operating Margin		 -33.72% -21.63% -13.47% -13.76% -6.97% -16.50% -8.00% 1.93% -5.06% -5.83% -6.17%
EBIT Margin		 -32.83% -20.77% -12.53% -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70% -4.75%
Profit (Net Income) Margin		 -32.95% -20.77% -12.53% -11.59% -5.30% -13.94% -5.68% 2.83% -3.81% -3.90% -5.39%
Tax Burden Percent		 100.37% 99.97% 100.01% 90.34% 100.91% 99.54% 102.76% 78.58% 110.20% 105.37% 113.59%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.24% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -103.83% -977.26% -452.56% -627.85% -147.15% -76.32% -68.43% -43.71% -30.06% -12.45% -14.16%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -41.88% -20.40% -16.30% -17.95% -6.58% -16.57% -7.41% 4.89% -4.36% -4.36% -6.26%
Return on Assets (ROA)		 -42.03% -20.39% -16.30% -16.22% -6.64% -16.50% -7.61% 3.84% -4.81% -4.59% -7.11%
Return on Common Equity (ROCE)		 3.08% -107.93% -11.83% -68.89% 35.28% -36.67% -36.96% -22.26% -7.49% -6.14% -7.30%
Return on Equity Simple (ROE_SIMPLE)		 -3,457.11% 0.00% 0.00% 0.00% 278.28% -80.36% -64.14% 0.00% -42.80% -24.70% 0.00%
Net Operating Profit after Tax (NOPAT)		 -49 -40 -29 -38 -18 -45 -26 8.68 -17 -22 -26
NOPAT Margin		 -23.60% -15.14% -9.43% -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08% -4.32%
Net Nonoperating Expense Percent (NNEP)		 -8.56% -6.49% -2.10% -1.70% -0.27% -1.33% -0.06% 1.07% -0.15% 0.10% -0.72%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -10.60% - - - -4.38% -5.32% -5.77%
Cost of Revenue to Revenue		 82.94% 83.94% 83.03% 85.00% 82.20% 92.32% 88.31% 82.92% 83.55% 80.38% 81.82%
SG&A Expenses to Revenue		 26.19% 19.07% 14.77% 17.08% 13.06% 12.37% 10.18% 8.04% 12.55% 14.25% 12.78%
R&D to Revenue		 24.59% 18.61% 15.66% 11.68% 11.71% 11.81% 9.51% 7.11% 8.96% 11.20% 8.81%
Operating Expenses to Revenue		 50.78% 37.69% 30.44% 28.76% 24.77% 24.18% 19.69% 15.15% 21.51% 25.45% 24.35%
Earnings before Interest and Taxes (EBIT)		 -68 -55 -39 -50 -19 -55 -26 20 -17 -20 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -66 -53 -37 -46 -16 -52 -15 27 -9.16 -8.07 -14
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1,146.73 5,086.00 8,863.57 226,609.56 0.00 131.75 104.59 75.77 71.97 57.75 104.21
Price to Tangible Book Value (P/TBV)		 1,276.20 6,204.87 10,250.45 0.00 0.00 131.75 104.59 77.20 77.90 1,083.09 326.35
Price to Revenue (P/Rev)		 8.45 13.48 21.32 15.79 21.44 17.82 12.42 8.36 7.39 5.73 10.01
Price to Earnings (P/E)		 678.45 367.39 448.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.15% 0.27% 0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 7.89 12.99 20.84 15.32 21.10 17.30 11.99 8.01 6.97 5.33 9.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 246.71 159.22 78.14 281.95 282.17 231.09 0.00 75.40 25.93 89.97
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.05 39.90 0.00 167.84 0.00 0.00 0.00 0.00 2,978.36 4,274.93 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.27 -21.57 -9.74 -13.57 -5.20 -3.41 -3.75 -3.50 -2.97 -2.44 -2.22
Leverage Ratio		 3.20 42.42 16.70 25.40 9.83 5.93 6.70 6.79 5.42 4.31 4.21
Compound Leverage Factor		 3.20 42.42 16.70 25.40 9.83 5.93 6.70 6.79 5.42 4.31 4.21
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 89.42% 88.96% 88.55% 103.02% 134.46% 49.93% 43.33% 49.44% 50.11% 51.27% 52.47%
Common Equity to Total Capital		 10.58% 11.04% 11.45% -3.02% -34.46% 50.07% 56.67% 50.56% 49.89% 48.73% 47.53%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 3.26 6.94 12.96 9.76 14.59 13.36 10.73 7.80 6.60 4.70 9.72
Noncontrolling Interest Sharing Ratio		 102.97% 88.96% 97.39% 89.03% 123.98% 51.95% 45.98% 49.07% 75.09% 50.63% 48.46%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.05 1.02 1.03 0.97 1.14 1.35 1.28 1.33 1.22 1.02 1.08
Quick Ratio		 0.81 0.77 0.75 0.72 0.88 1.13 1.05 1.13 1.05 0.85 0.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 649 401 121 226 94 71 8.07 -121 69 39 -110
Operating Cash Flow to CapEx		 1,445.67% 520.39% 732.76% 4,623.88% -1,007.35% 733.96% 293.90% -465.12% 2,786.83% 1,311.16% -930.54%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.28 0.98 1.30 1.40 1.25 1.18 1.34 1.36 1.26 1.18 1.32
Accounts Receivable Turnover		 0.00 4.75 12.26 7.96 6.07 6.41 8.98 5.86 5.89 7.34 7.62
Inventory Turnover		 0.00 5.32 5.86 8.66 8.95 9.62 9.55 12.73 13.42 13.02 13.29
Fixed Asset Turnover		 0.00 25.13 33.52 39.64 40.79 26.35 27.14 27.17 27.34 20.84 28.47
Accounts Payable Turnover		 19.40 8.47 10.06 11.07 13.60 11.30 14.12 10.82 10.70 9.81 10.49
Days Sales Outstanding (DSO)		 0.00 76.84 29.77 45.84 60.17 56.94 40.64 62.27 61.97 49.73 47.92
Days Inventory Outstanding (DIO)		 0.00 68.64 62.23 42.16 40.80 37.96 38.24 28.66 27.19 28.03 27.46
Days Payable Outstanding (DPO)		 18.82 43.08 36.29 32.98 26.84 32.29 25.86 33.73 34.11 37.22 34.80
Cash Conversion Cycle (CCC)		 -18.82 102.40 55.71 55.02 74.13 62.61 53.02 57.20 55.06 40.54 40.58
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -397 -441 -489 -548 -509 -558 -524 -418 -595 -619 -440
Invested Capital Turnover		 -15.00 -4.05 -2.49 -2.83 -2.94 -2.92 -3.27 -3.70 -3.47 -3.52 -4.55
Increase / (Decrease) in Invested Capital		 -698 -441 -151 -264 -112 -117 -34 130 -86 -61 84
Enterprise Value (EV)		 5,702 11,600 21,454 18,034 28,080 25,213 19,835 14,328 13,353 11,038 21,313
Market Capitalization		 6,104 12,044 21,946 18,582 28,532 25,968 20,556 14,944 14,145 11,862 21,963
Book Value per Share		 $0.01 $0.00 $0.00 $0.00 ($0.69) $0.34 $0.34 $0.34 $0.33 $0.35 $0.36
Tangible Book Value per Share		 $0.01 $0.00 $0.00 $0.00 ($0.69) $0.34 $0.34 $0.33 $0.31 $0.02 $0.11
Total Capital		 50 21 22 -2.72 166 394 347 390 394 422 443
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -448 -462 -511 -546 -675 -951 -870 -809 -989 -1,040 -883
Capital Expenditures (CapEx)		 6.99 6.02 7.36 0.96 2.99 2.87 17 21 7.36 21 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -411 -446 -487 -579 -520 -578 -580 -389 -641 -930 -669
Debt-free Net Working Capital (DFNWC)		 36 17 24 -34 155 373 291 338 262 25 109
Net Working Capital (NWC)		 36 17 24 -34 155 373 291 338 262 25 109
Net Nonoperating Expense (NNE)		 19 15 9.67 7.66 1.50 9.40 0.39 -7.27 1.28 -1.00 6.34
Net Nonoperating Obligations (NNO)		 -448 -462 -511 -546 -675 -951 -870 -809 -989 -1,040 -883
Total Depreciation and Amortization (D&A)		 2.08 2.07 2.46 4.71 3.20 3.16 11 6.43 7.65 12 14
Debt-free, Cash-free Net Working Capital to Revenue		 -56.92% -49.92% -47.33% -49.21% -39.07% -39.70% -35.03% -21.75% -33.50% -44.88% -30.50%
Debt-free Net Working Capital to Revenue		 5.02% 1.86% 2.30% -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23% 4.96%
Net Working Capital to Revenue		 5.02% 1.86% 2.30% -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23% 4.96%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.12) ($0.10) ($0.07) ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding		 58.24M 60.50M 61.78M 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M
Adjusted Diluted Earnings per Share		 ($0.12) ($0.10) ($0.07) ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding		 58.24M 60.50M 61.78M 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M 109.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 555.52M 555.46M 555.85M 557.24M 0.00 584.63M 585.58M 587.42M 588.39M 589.61M 590.49M
Normalized Net Operating Profit after Tax (NOPAT)		 -49 -40 -29 -38 -18 -45 -26 8.68 -17 -22 -14
Normalized NOPAT Margin		 -23.60% -15.14% -9.43% -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08% -2.39%
Pre Tax Income Margin		 -32.83% -20.77% -12.53% -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70% -4.75%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47% -3.10%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47% -3.10%

Key Financial Trends

Symbotic Inc. (NASDAQ: SYM) has shown a mixed financial performance over the last four years through Q3 2025, with notable growth in revenue but persistent net losses and significant fluctuations in cash flows and equity.

Positive Trends:

  • Consistent revenue growth: Quarterly operating revenue increased from approximately $175.6M in Q3 2022 to $592.1M in Q3 2025, reflecting strong top-line growth over the period.
  • Increasing gross profit: Total gross profit rose from $31.5M in Q3 2022 to $107.6M in Q3 2025, indicating improved core operational profitability alongside revenue expansion.
  • Strong cash from operations in early 2025: Positive net cash from continuing operating activities was recorded in Q1 and Q2 2025 ($205M and $269.6M respectively), demonstrating solid cash generation capability during those quarters.
  • Significant growth in total assets: Total assets increased substantially from $612.8M in Q3 2022 to $1.83B in Q3 2025, showing investment in expansion and asset base growth.
  • Increasing common stock equity: Common stock value grew from roughly $1.23B in Q3 2022 to $1.55B by Q3 2025, indicating capital raises likely fueling growth initiatives.

Neutral Aspects:

  • Stable research & development expenses hovered around $40M-$52M per quarter, emphasizing continuous investment in innovation without drastic escalations.
  • Depreciation expense increased modestly over time, consistent with asset growth and capital expenditures.
  • Noncontrolling interests consistently represent a significant portion of net income/loss, highlighting the influence of minority shareholders.

Negative Trends:

  • Persistent net losses: Symbotic has reported losses every quarter analyzed, including a $31.9M net loss in Q3 2025, reflecting ongoing challenges in achieving profitability despite rising revenue.
  • Negative operating cash flow in Q3 2025: Net cash from operating activities swung dramatically negative (-$138M), driven largely by increased operating assets and liabilities, which may imply working capital strain.
  • Significant cash outflows for acquisitions and capital expenditures: In Q3 2025 alone, acquisitions and property, plant, and equipment purchases totaled nearly $39M in cash outflow, which, while potentially growth-oriented, increases cash burn and investment risk.
  • Equity fluctuations and negative retained earnings: The retained earnings remain in large negative territory (around -$1.33B in Q3 2025), reflecting accumulated losses over time despite capital injections.
  • Rising liabilities, especially current liabilities, reached $1.32B by Q3 2025, which could pressure liquidity if cash generation does not improve.

Summary: Symbotic displays robust revenue and asset growth, signaling expansion and market traction. However, the consistent net losses, negative operating cash flow in the most recent quarter, and heavy cash outlays for acquisitions and capital expenditures highlight ongoing financial challenges. Investors should weigh Symbotic’s growth potential against its path to profitability and cash flow sustainability risks.

08/17/25 09:50 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Smead Value C's Financials

When does Smead Value C's financial year end?

According to the most recent income statement we have on file, Smead Value C's fiscal year ends in September. Their fiscal year 2024 ended on September 28, 2024.

How has Smead Value C's net income changed over the last 4 years?

Smead Value C's net income appears to be on an upward trend, with a most recent value of -$84.67 million in 2024, falling from -$109.52 million in 2020. The previous period was -$207.89 million in 2023.

What is Smead Value C's operating income?
Smead Value C's total operating income in 2024 was -$116.73 million, based on the following breakdown:
  • Total Gross Profit: $245.67 million
  • Total Operating Expenses: $362.39 million
How has Smead Value C's revenue changed over the last 4 years?

Over the last 4 years, Smead Value C's total revenue changed from $92.09 million in 2020 to $1.79 billion in 2024, a change of 1,841.9%.

How much debt does Smead Value C have?

Smead Value C's total liabilities were at $1.19 billion at the end of 2024, a 12.8% increase from 2023, and a 937,511.0% increase since 2020.

How much cash does Smead Value C have?

In the past 4 years, Smead Value C's cash and equivalents has ranged from $0.00 in 2020 to $727.31 million in 2024, and is currently $727.31 million as of their latest financial filing in 2024.

How has Smead Value C's book value per share changed over the last 4 years?

Over the last 4 years, Smead Value C's book value per share changed from 0.00 in 2020 to 0.34 in 2024, a change of 168,300.0%.


Related Companies

This page (NASDAQ:SVFCX) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
New Federal Land Rush About to Start?
A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...
Stansberry Research | Sponsored